Invenire Partners, LP Sensus Healthcare, Inc. Transaction History
Invenire Partners, LP
- $65.3 Million
- Q3 2022
A detailed history of Invenire Partners, LP transactions in Sensus Healthcare, Inc. stock. As of the latest transaction made, Invenire Partners, LP holds 118,867 shares of SRTS stock, worth $633,561. This represents 100.0% of its overall portfolio holdings.
Number of Shares
118,867Holding current value
$633,561% of portfolio
100.0%Shares
1 transactions
Others Institutions Holding SRTS
# of Institutions
48Shares Held
2.47MCall Options Held
2.2KPut Options Held
3K-
Vanguard Group Inc Valley Forge, PA779KShares$4.15 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny291KShares$1.55 Million0.0% of portfolio
-
Perritt Capital Management Inc Chicago, IL131KShares$696,0230.28% of portfolio
-
Geode Capital Management, LLC Boston, MA128KShares$680,1980.0% of portfolio
-
Sachetta, LLC Lynnfield, MA105KShares$558,6370.12% of portfolio
About Sensus Healthcare, Inc.
- Ticker SRTS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 16,556,000
- Market Cap $88.2M
- Description
- Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provide...